Last Updated 26 September 2022.
8 Vaccines Approved for Use in Viet Nam
-
Center for Genetic Engineering and Biotechnology (CIGB)
Abdala- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 6 countries
5 trials in 1 country
Approval Source: cnn.com
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
69 trials in 24 countries
Approval Source: reuters.com
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
96 trials in 31 countries
Approval Source: channelnewsasia.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
25 trials in 8 countries
Approval Source: reuters.com
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
71 trials in 33 countries
Approval Source: channelnewsasia.com
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 14 countries
15 trials in 2 countries
Approval Source: reuters.com
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 93 countries
38 trials in 17 countries
Approval Source: reuters.com
9 Vaccines in Clinical Trials in Viet Nam
-
Laboratorios Hipra SA
COVID-19 vaccine HIPRA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
10 trials in 4 countries
-
Medigen
MVC-COV1901- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
15 trials in 4 countries
-
Nanogen
Nanocovax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 1 country
-
Shionogi
S-268019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
9 trials in 2 countries
-
SK Bioscience Co Ltd
SKYCovione- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
7 trials in 6 countries
-
Arcturus Therapeutics Inc
ARCT-154- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 3 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
96 trials in 31 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
71 trials in 33 countries
-
Institute of Vaccines and Medical Biologicals
COVIVAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries